寡转移性骨转移患者接受常规或立体定向放疗的患者报告结局:PRESENT队列分析
该研究基于前瞻性PRESENT队列,比较常规三维适形放疗与立体定向体部放疗对寡转移性骨转移患者的疼痛缓解和生活质量影响。结果显示两组疼痛缓解率和生活质量无显著差异,但SBRT组再照射需求更低。
要点
- SBRT与3DCRT在寡转移性骨转移患者中疼痛缓解率和生活质量无显著差异。
- SBRT组再照射需求(5%)显著低于3DCRT组(33%)。
- 两组疼痛缓解中位持续时间相似(23周 vs 24周)。
核心结论
- 在寡转移性疾病患者中,骨转移灶SBRT相比3DCRT并未改善疼痛缓解或生活质量,但SBRT组再照射需求更少。
研究设计与样本
- 前瞻性PRESENT队列分析,纳入寡转移性疾病(≤5个病灶且≤3个器官)患者131例,其中66例接受3DCRT,65例接受SBRT。
主要发现
- 疼痛缓解率3DCRT组为81%,SBRT组为84%,中位缓解持续时间分别为23周(范围1-58)和24周(范围0-50)。
- 再照射需求3DCRT组为33%,SBRT组为5%。
- 两组生活质量的各子量表均无显著差异。
关键数值与推荐
- 疼痛缓解仅评估基线有疼痛的患者,依据国际共识标准定义。
- 主要结局为治疗后2、4、8周及3、6、12个月的疼痛缓解、临床局部控制和生活质量。
临床怎么用
- 对于寡转移性骨转移患者,SBRT可作为减少再照射需求的选项,但不应期望其比3DCRT带来更好的疼痛缓解或生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stereotactic body radiation therapy (SBRT) has become a widely adopted treatment for patients with oligometastatic disease, despite limited evidence of superiority. We compared pain response and quality of life (QoL) in patients with oligometastatic disease treated with conventionally fractionated 3-dimensional radiation therapy (3DCRT) or SBRT to bone metastases. METHODS AND MATERIALS: We included patients with oligometastatic disease (≤5 lesions within ≤3 organs) treated within the prospective PRESENT cohort. Main outcomes were pain response, clinical local control, and QoL 2, 4, and 8 weeks and 3, 6, and 12 months after treatment. Pain response was assessed only in patients who reported pain at baseline and was defined according to international consensus criteria. RESULTS: Of 131 patients with oligometastatic disease, 66 patients were treated with 3DCRT and 65 patients with SBRT. A pain response was achieved in 81% (3DCRT) versus 84% (SBRT) with a median duration of 23 weeks (range, 1-58) and 24 weeks (range, 0-50), respectively. Reirradiation was needed in 33% versus 5% of the patients, respectively. None of the QoL subscales were significantly different between both groups. CONCLUSIONS: In patients with oligometastatic disease, SBRT to bone metastases did not improve pain response or QoL compared with 3DCRT. Reirradiation was less often needed in the SBRT group.
引用
- van de Ven S, van den Bongard D, Pielkenrood B, et al. Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort. Int J Radiat Oncol Biol Phys. 2020. PMID: 32007565. doi:10.1016/j.ijrobp.2019.12.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。